AR063618A1 - Composicion farmaceutica - Google Patents
Composicion farmaceuticaInfo
- Publication number
- AR063618A1 AR063618A1 ARP070104976A ARP070104976A AR063618A1 AR 063618 A1 AR063618 A1 AR 063618A1 AR P070104976 A ARP070104976 A AR P070104976A AR P070104976 A ARP070104976 A AR P070104976A AR 063618 A1 AR063618 A1 AR 063618A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- isoindoline
- pentamethyl
- absorbability
- benzofuran
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee una composición farmacéutica que comprende (1) (R)-5,6-dimetoxi-2-[2,2,4,6,7-pentametil-3-(4-metil-fenil)-2,3-dihidro-1-benzofuran-5-il]isoindolina, ( 2) un componente lipofílico y (3) un agente tensioactivo, que puede proveer en forma estable y suficiente mejoramiento de la absorbabilidad del fármaco sin ser afectado por la cantidad y calidad de una comida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006303800 | 2006-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR063618A1 true AR063618A1 (es) | 2009-02-04 |
Family
ID=38942774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070104976A AR063618A1 (es) | 2006-11-09 | 2007-11-08 | Composicion farmaceutica |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100273852A1 (es) |
EP (1) | EP2079455B1 (es) |
JP (1) | JP2010509188A (es) |
AR (1) | AR063618A1 (es) |
AT (1) | ATE456365T1 (es) |
CA (1) | CA2668864A1 (es) |
CL (1) | CL2007003217A1 (es) |
DE (1) | DE602007004642D1 (es) |
PE (1) | PE20081491A1 (es) |
TW (1) | TW200833374A (es) |
WO (1) | WO2008056822A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6982870B2 (ja) * | 2015-05-06 | 2021-12-17 | シンアジャル コーポレイション | 薬物粒子を含有する医薬懸濁液、それらの投与のためのデバイス、およびそれらの使用方法 |
JP7492917B2 (ja) | 2018-02-09 | 2024-05-30 | デシベル セラピューティクス インコーポレイテッド | 抗白金化学保護剤を含む高張医薬組成物 |
US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
ATE261435T1 (de) * | 1998-12-04 | 2004-03-15 | Takeda Chemical Industries Ltd | Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen |
CN1431896A (zh) * | 2000-04-04 | 2003-07-23 | 盐野义制药株式会社 | 含有高脂溶性药物的油性组合物 |
CA2432410A1 (en) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Process for preparing optically active 2,3-dihydro- benzofuran compounds |
WO2003051355A1 (fr) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes |
KR101011657B1 (ko) * | 2002-03-01 | 2011-01-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 항우울제 |
-
2007
- 2007-11-08 TW TW096142176A patent/TW200833374A/zh unknown
- 2007-11-08 CL CL200703217A patent/CL2007003217A1/es unknown
- 2007-11-08 CA CA002668864A patent/CA2668864A1/en not_active Abandoned
- 2007-11-08 DE DE602007004642T patent/DE602007004642D1/de active Active
- 2007-11-08 US US12/513,847 patent/US20100273852A1/en not_active Abandoned
- 2007-11-08 AT AT07831871T patent/ATE456365T1/de not_active IP Right Cessation
- 2007-11-08 WO PCT/JP2007/072141 patent/WO2008056822A1/en active Application Filing
- 2007-11-08 EP EP07831871A patent/EP2079455B1/en not_active Not-in-force
- 2007-11-08 PE PE2007001543A patent/PE20081491A1/es not_active Application Discontinuation
- 2007-11-08 JP JP2009517780A patent/JP2010509188A/ja not_active Withdrawn
- 2007-11-08 AR ARP070104976A patent/AR063618A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2079455B1 (en) | 2010-01-27 |
US20100273852A1 (en) | 2010-10-28 |
ATE456365T1 (de) | 2010-02-15 |
CL2007003217A1 (es) | 2008-07-04 |
DE602007004642D1 (de) | 2010-03-18 |
JP2010509188A (ja) | 2010-03-25 |
WO2008056822A1 (en) | 2008-05-15 |
CA2668864A1 (en) | 2008-05-15 |
TW200833374A (en) | 2008-08-16 |
EP2079455A1 (en) | 2009-07-22 |
PE20081491A1 (es) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201070568A1 (ru) | Фармацевтические составы | |
MX2009004861A (es) | Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa. | |
EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
CY1109719T1 (el) | Σκευασμα 1-[(3-υδροξυ-αδαμαντ-1-υλαμινο)-ακετυλο]-πυρρολιδινο-2-(s)-καρβονιτριλιου τροποποιημενης απελευθερωσης | |
GT200600200A (es) | Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato | |
UY31647A1 (es) | Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa | |
CY1113128T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
MA30765B1 (fr) | Derives innovants du thiophene | |
AR062860A1 (es) | Combinaciones terapeuticas 482 | |
MX2007005205A (es) | Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma. | |
EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
ATE555777T1 (de) | Pharmazeutische zusammensetzung | |
AR079208A2 (es) | Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica | |
EA201170512A1 (ru) | Композиция для перорального введения | |
CR8371A (es) | Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
CR9632A (es) | Tableta que contiene un ingrediente dificilmente soluble | |
NO20074933L (no) | Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat | |
EA201100752A1 (ru) | Фармацевтические пероральные композиции с пролонгированным высвобождением, включающие производные 2-оксо-1-пирролидина | |
ECSP066872A (es) | Tabletas desintegrantes que comprenden licarbazepina | |
CY1115955T1 (el) | Ενα στερεο φαρμακευτικο σκευασμα | |
CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
WO2008081829A1 (ja) | 難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |